Titre : Anomalies du tube neural

Anomalies du tube neural : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reference Values
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Anomalies du tube neural : Questions médicales les plus fréquentes", "headline": "Anomalies du tube neural : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Anomalies du tube neural : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-16", "dateModified": "2025-03-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Anomalies du tube neural" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Malformations du système nerveux", "url": "https://questionsmedicales.fr/mesh/D009421", "about": { "@type": "MedicalCondition", "name": "Malformations du système nerveux", "code": { "@type": "MedicalCode", "code": "D009421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C16.131.666" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anencéphalie", "alternateName": "Anencephaly", "url": "https://questionsmedicales.fr/mesh/D000757", "about": { "@type": "MedicalCondition", "name": "Anencéphalie", "code": { "@type": "MedicalCode", "code": "D000757", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C16.131.666.680.196" } } }, { "@type": "MedicalWebPage", "name": "Malformation d'Arnold-Chiari", "alternateName": "Arnold-Chiari Malformation", "url": "https://questionsmedicales.fr/mesh/D001139", "about": { "@type": "MedicalCondition", "name": "Malformation d'Arnold-Chiari", "code": { "@type": "MedicalCode", "code": "D001139", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C16.131.666.680.291" } } }, { "@type": "MedicalWebPage", "name": "Myéloméningocèle", "alternateName": "Meningomyelocele", "url": "https://questionsmedicales.fr/mesh/D008591", "about": { "@type": "MedicalCondition", "name": "Myéloméningocèle", "code": { "@type": "MedicalCode", "code": "D008591", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C16.131.666.680.610" } } }, { "@type": "MedicalWebPage", "name": "Pentalogie de Cantrell", "alternateName": "Pentalogy of Cantrell", "url": "https://questionsmedicales.fr/mesh/D058502", "about": { "@type": "MedicalCondition", "name": "Pentalogie de Cantrell", "code": { "@type": "MedicalCode", "code": "D058502", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C16.131.666.680.705" } } }, { "@type": "MedicalWebPage", "name": "Dysraphie spinale", "alternateName": "Spinal Dysraphism", "url": "https://questionsmedicales.fr/mesh/D016135", "about": { "@type": "MedicalCondition", "name": "Dysraphie spinale", "code": { "@type": "MedicalCode", "code": "D016135", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C16.131.666.680.800" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Spina bifida cystica", "alternateName": "Spina Bifida Cystica", "url": "https://questionsmedicales.fr/mesh/D016137", "about": { "@type": "MedicalCondition", "name": "Spina bifida cystica", "code": { "@type": "MedicalCode", "code": "D016137", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C16.131.666.680.800.730" } } }, { "@type": "MedicalWebPage", "name": "Spina bifida occulta", "alternateName": "Spina Bifida Occulta", "url": "https://questionsmedicales.fr/mesh/D016136", "about": { "@type": "MedicalCondition", "name": "Spina bifida occulta", "code": { "@type": "MedicalCode", "code": "D016136", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C16.131.666.680.800.750" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Anomalies du tube neural", "alternateName": "Neural Tube Defects", "code": { "@type": "MedicalCode", "code": "D009436", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Richard H Finnell", "url": "https://questionsmedicales.fr/author/Richard%20H%20Finnell", "affiliation": { "@type": "Organization", "name": "Department of Molecular and Human Genetics and Medicine, Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX, United States." } }, { "@type": "Person", "name": "Zhiwen Li", "url": "https://questionsmedicales.fr/author/Zhiwen%20Li", "affiliation": { "@type": "Organization", "name": "National Health Commission Key Laboratory of Reproductive Health, Department of Epidemiology and Biostatistics, Institute of Reproductive and Child Health, School of Public Health, Peking University Health Science Center, Beijing, China." } }, { "@type": "Person", "name": "Lei Jin", "url": "https://questionsmedicales.fr/author/Lei%20Jin", "affiliation": { "@type": "Organization", "name": "National Health Commission Key Laboratory of Reproductive Health, Department of Epidemiology and Biostatistics, Institute of Reproductive and Child Health, School of Public Health, Peking University Health Science Center, Beijing, China." } }, { "@type": "Person", "name": "Linlin Wang", "url": "https://questionsmedicales.fr/author/Linlin%20Wang", "affiliation": { "@type": "Organization", "name": "National Health Commission Key Laboratory of Reproductive Health, Department of Epidemiology and Biostatistics, Institute of Reproductive and Child Health, School of Public Health, Peking University Health Science Center, Beijing, China." } }, { "@type": "Person", "name": "Aiguo Ren", "url": "https://questionsmedicales.fr/author/Aiguo%20Ren", "affiliation": { "@type": "Organization", "name": "National Health Commission Key Laboratory of Reproductive Health, Department of Epidemiology and Biostatistics, Institute of Reproductive and Child Health, School of Public Health, Peking University Health Science Center, Beijing, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "An initial set of reference values for the Balance Tracking System (BTrackS) Limits of Stability protocol.", "datePublished": "2023-09-16", "url": "https://questionsmedicales.fr/article/37757595", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gaitpost.2023.09.008" } }, { "@type": "ScholarlyArticle", "name": "General population reference values for the Functional Assessment of Cancer Therapy-Lung and PROMIS-29.", "datePublished": "2023-05-06", "url": "https://questionsmedicales.fr/article/37148552", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.5920" } }, { "@type": "ScholarlyArticle", "name": "Age-adjusted reference values and influencing factors of cystatin C in healthy Chinese population.", "datePublished": "2023-02-03", "url": "https://questionsmedicales.fr/article/36735151", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11255-023-03497-1" } }, { "@type": "ScholarlyArticle", "name": "Reference values of bone mineral density of proximal femur for Southeast Asian children and adolescents.", "datePublished": "2022-11-19", "url": "https://questionsmedicales.fr/article/36400873", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11657-022-01184-9" } }, { "@type": "ScholarlyArticle", "name": "Amplitude integrated electroencephalography - Reference values in children aged 2 months to 16 years.", "datePublished": "2022-09-03", "url": "https://questionsmedicales.fr/article/36001056", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/apa.16520" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Malformations et maladies congénitales, héréditaires et néonatales", "item": "https://questionsmedicales.fr/mesh/D009358" }, { "@type": "ListItem", "position": 3, "name": "Malformations", "item": "https://questionsmedicales.fr/mesh/D000013" }, { "@type": "ListItem", "position": 4, "name": "Malformations du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009421" }, { "@type": "ListItem", "position": 5, "name": "Anomalies du tube neural", "item": "https://questionsmedicales.fr/mesh/D009436" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Anomalies du tube neural - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Anomalies du tube neural", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Anomalies du tube neural", "description": "Comment diagnostique-t-on une anomalie du tube neural ?\nQuels examens sont utilisés pour confirmer le diagnostic ?\nÀ quel moment le diagnostic est-il généralement posé ?\nQuels signes échographiques indiquent une anomalie ?\nPeut-on détecter ces anomalies après la naissance ?", "url": "https://questionsmedicales.fr/mesh/D009436?mesh_terms=Reference+Values&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Anomalies du tube neural", "description": "Quels sont les symptômes d'une anomalie du tube neural ?\nLes anomalies du tube neural causent-elles des douleurs ?\nComment se manifestent les anomalies après la naissance ?\nLes anomalies du tube neural affectent-elles la cognition ?\nY a-t-il des signes visibles à la naissance ?", "url": "https://questionsmedicales.fr/mesh/D009436?mesh_terms=Reference+Values&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Anomalies du tube neural", "description": "Comment prévenir les anomalies du tube neural ?\nQuel est le dosage recommandé d'acide folique ?\nY a-t-il d'autres mesures préventives ?\nLes vaccinations influencent-elles le risque ?\nLes antécédents familiaux augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D009436?mesh_terms=Reference+Values&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Anomalies du tube neural", "description": "Quels traitements sont disponibles pour ces anomalies ?\nLa chirurgie est-elle toujours nécessaire ?\nQuels types de rééducation sont recommandés ?\nY a-t-il des traitements médicamenteux ?\nComment le soutien psychologique aide-t-il ?", "url": "https://questionsmedicales.fr/mesh/D009436?mesh_terms=Reference+Values&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Anomalies du tube neural", "description": "Quelles complications peuvent survenir ?\nLes anomalies du tube neural peuvent-elles entraîner des décès ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des complications à long terme ?\nLes complications sont-elles évitables ?", "url": "https://questionsmedicales.fr/mesh/D009436?mesh_terms=Reference+Values&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Anomalies du tube neural", "description": "Quels sont les principaux facteurs de risque ?\nL'âge maternel influence-t-il le risque ?\nLes médicaments peuvent-ils augmenter le risque ?\nLe poids maternel joue-t-il un rôle ?\nLes infections pendant la grossesse sont-elles un risque ?", "url": "https://questionsmedicales.fr/mesh/D009436?mesh_terms=Reference+Values&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une anomalie du tube neural ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par échographie prénatale et tests génétiques." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour confirmer le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'amniocentèse et l'échographie 3D peuvent confirmer les anomalies." } }, { "@type": "Question", "name": "À quel moment le diagnostic est-il généralement posé ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic est souvent posé entre la 12e et la 20e semaine de grossesse." } }, { "@type": "Question", "name": "Quels signes échographiques indiquent une anomalie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'absence de boîte crânienne ou des malformations vertébrales." } }, { "@type": "Question", "name": "Peut-on détecter ces anomalies après la naissance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines anomalies peuvent être détectées par examen physique après la naissance." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une anomalie du tube neural ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des problèmes neurologiques, des malformations crâniennes et des troubles moteurs." } }, { "@type": "Question", "name": "Les anomalies du tube neural causent-elles des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les douleurs ne sont pas typiques, mais des complications peuvent entraîner des douleurs." } }, { "@type": "Question", "name": "Comment se manifestent les anomalies après la naissance ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent se manifester par des difficultés motrices et des retards de développement." } }, { "@type": "Question", "name": "Les anomalies du tube neural affectent-elles la cognition ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent affecter la cognition, selon la gravité et le type d'anomalie." } }, { "@type": "Question", "name": "Y a-t-il des signes visibles à la naissance ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des signes comme une hernie spinale ou des malformations crâniennes peuvent être visibles." } }, { "@type": "Question", "name": "Comment prévenir les anomalies du tube neural ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prise d'acide folique avant et pendant la grossesse réduit le risque." } }, { "@type": "Question", "name": "Quel est le dosage recommandé d'acide folique ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un dosage de 400 à 800 microgrammes par jour est recommandé pour les femmes enceintes." } }, { "@type": "Question", "name": "Y a-t-il d'autres mesures préventives ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'alcool et le tabac, et gérer les maladies chroniques sont également importants." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations sont recommandées pour protéger la santé maternelle et fœtale." } }, { "@type": "Question", "name": "Les antécédents familiaux augmentent-ils le risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'anomalies du tube neural peuvent augmenter le risque." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour ces anomalies ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la rééducation et le soutien psychologique." } }, { "@type": "Question", "name": "La chirurgie est-elle toujours nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, la nécessité de la chirurgie dépend de la gravité de l'anomalie." } }, { "@type": "Question", "name": "Quels types de rééducation sont recommandés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La rééducation physique et l'orthophonie sont souvent recommandées." } }, { "@type": "Question", "name": "Y a-t-il des traitements médicamenteux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour gérer les symptômes associés." } }, { "@type": "Question", "name": "Comment le soutien psychologique aide-t-il ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Il aide les familles à faire face aux défis émotionnels et pratiques des anomalies." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections, des troubles neurologiques et des problèmes de mobilité." } }, { "@type": "Question", "name": "Les anomalies du tube neural peuvent-elles entraîner des décès ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines anomalies graves peuvent entraîner des décès néonatals." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent limiter les activités quotidiennes et nécessiter des soins constants." } }, { "@type": "Question", "name": "Y a-t-il des complications à long terme ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications à long terme peuvent inclure des troubles cognitifs et moteurs." } }, { "@type": "Question", "name": "Les complications sont-elles évitables ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par un suivi médical approprié." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, le diabète et la carence en acide folique." } }, { "@type": "Question", "name": "L'âge maternel influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes de plus de 35 ans ont un risque accru d'anomalies du tube neural." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils augmenter le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments, comme les antiépileptiques, peuvent augmenter le risque." } }, { "@type": "Question", "name": "Le poids maternel joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité maternelle est un facteur de risque pour les anomalies du tube neural." } }, { "@type": "Question", "name": "Les infections pendant la grossesse sont-elles un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections, comme la rubéole, peuvent augmenter le risque d'anomalies." } } ] } ] }

Sources (10000 au total)

An initial set of reference values for the Balance Tracking System (BTrackS) Limits of Stability protocol.

The Balance Tracking System (BTrackS) Limits of Stability (LOS) protocol is a relatively new means of evaluating unconstrained dynamic postural control ability. While the reliability of this protocol ... What are typical reference values for the BTrackS LOS protocol with respect to sex, height, and BMI?... A cross= -section of 800 healthy, young adults (aged 18-29 years; 368 men, 432 women) were administered the BTrackS LOS protocol. Sex, height and weight variables were also captured for the participan... Results of a stepwise linear regression showed that the outcome measure for BTrackS LOS testing (i.e. LOS Area) was larger in taller individuals and in men. Based on these findings, four percentile ra... The reference values provided by this study offer much needed guidance to clinicians and researchers for the determination of dynamic balance abnormalities based on BTrackS LOS testing....

General population reference values for the Functional Assessment of Cancer Therapy-Lung and PROMIS-29.

Therapeutic advances in lung cancer have turned attention toward patient-reported outcome measures (PROMs) as important clinical outcomes. The Functional Assessment of Cancer Therapy-Lung (FACT-L) is ... Adults from the US general population (N = 2001) were surveyed between September 2020 and November 2020. Surveys contained 126 questions, including the FACT-L [36 items; FACT-G and four subscales (Phy... In the total sample, the reference scores were as follows: PWB = 23.1; SWB = 16.8; EWB = 18.5; FWB = 17.6; FACT-G = 76.0; LCS = 23.0, TOI = 63.7, and FACT-L Total = 99.0. Scores were lower for those r... These data provide US general adult population reference value set for FACT-L. While some of the subscale results were lower than those found in the reference data for other PROMs, these data were obt...

Age-adjusted reference values and influencing factors of cystatin C in healthy Chinese population.

Normative distribution of serum cystatin C and relationship with sex and age in healthy adult Chinese population is unknown.... This is a prospective cohort study. Adult subjects (18 years of age and older) who underwent annual health examination at the Health Management Center in Sir Run Run Hospital were eligible. Subjects w... The final analysis included a total of 10,640 subjects (40 ± 12 years, 52% men). The median serum cystatin C concentration was 0.73 mg/L (95% CI 0.52-1.03 mg/L) in the overall analysis, 0.79 (95% CI 0... The median serum cystatin C concentration was 0.73 (95% CI 0.52-1.03 mg/L) in healthy adult Chinese population, 0.79 (95% CI 0.59-1.07 mg/L) in men, and 0.67 (95% CI 0.49-0.95 mg/L) in women. Elevated...

Reference values of bone mineral density of proximal femur for Southeast Asian children and adolescents.

Bone mineral density (BMD) of the proximal femur helps evaluate bone density in children with reduced mechanical loading of the lower extremities. This study provides the first reference values of bon... Proximal femur scans of 170 boys and 191 girls obtained from DXA (Lunar Prodigy Pro, GE, and software enCORE version 7.53) were un-analyzed and then re-analyzed with the upgraded software enCORE versi... Sex and Tanner stage-specific BMD normative data were generated. BMD values of the femoral neck and total hip increased with age and pubertal progression. FNBMAD values were not markedly influenced by... We established normative reference data for BMD of the proximal femur measured by DXA in Thai children aged 5 to 18 years. Our reference data will help clinicians and researchers assess and interpret ...

Amplitude integrated electroencephalography - Reference values in children aged 2 months to 16 years.

Amplitude integrated electroencephalography (aEEG) is a bedside neuromonitoring tool, standard within neonatal critical care provision. Its application in children is increasing but normative data und... This retrospective observational cohort study derives aEEG normative amplitude characteristics from electroencephalograms (EEGs) recorded in Children's Health Ireland at Crumlin. aEEG was derived from... aEEG amplitudes vary with age and state, increasing over the first 2 years of life before diminishing. Upper and lower margin amplitudes and bandwidth are greater during sleep for children <6 years. R... aEEG traces evolve with age in childhood and differ from neonatal values. We provide a comprehensive set of aEEG normatives to facilitate clinical interpretation in older children....

Comparison of oral hypofunction tests and determination of reference values for a subjective masticatory function test.

In Japan, oral hypofunction has been recognized as a disease since 2018. An alternative to occlusal force testing for assessing oral hypofunction is the evaluation of the number of natural teeth. Subj... The sample consisted of 184 older adults who visited the Department of Geriatric Dentistry, Showa University Dental Hospital, from July 2018 to January 2020. The subjective masticatory function test (... A significant correlation (r) was found between the occlusal force test and the Chewing Score 20 (r = 0.526, p < 0.001). The reference value for Chewing Score 20 was < 85. Although the Chewing Score 2... Herein, a score of < 85 on the subjective masticatory function test was determined to be the optimal quantitative reference. The subjective masticatory function test may be used as an alternative for ...

Reference values for wrist-worn accelerometer physical activity metrics in England children and adolescents.

Over the last decade use of raw acceleration metrics to assess physical activity has increased. Metrics such as Euclidean Norm Minus One (ENMO), and Mean Amplitude Deviation (MAD) can be used to gener... Wrist-worn accelerometer data from 10 studies involving youth aged 5 to 15 y were pooled. Weekday and weekend waking hours were first calculated for youth in school Years (Y) 1&2, Y4&5, Y6&7, and Y8&9... The analytical sample included 1250 participants. Physical activity peaked between ages 6.5-10.5 y, depending on metric. For all metrics the highest activity levels occurred in less active participant... Percentile reference values for average acceleration, intensity gradient, and MX metrics have utility in describing age- and sex-specific values for physical activity volume and intensity in youth. Th...

Relationship between age and handgrip strength: Proposal of reference values from infancy to senescence.

Measurement of hand grip strength (HGS) has been proposed as a key component of frailty and has also been suggested as a central biomarker of healthy aging and a powerful predictor of future morbidity... (a) To determine whether a nonlinear relationship model could improve the prediction of handgrip strength (HGS) compared to the linear model and (b) to propose percentiles to evaluate HGS according to... A cross-sectional descriptive study was developed in a representative sample of the Maule region (Chile). The volunteers amounted to 5,376 participants (2,840 men and 2,536 women), with an age range f... There were no differences in HGS from 6 to 11 years of age in both sexes; however, from 12 years of age onwards, males presented higher HGS values in both hands (...

Reference values for paediatric abdominal aorta on B-mode ultrasound - an outer-to-outer methodology.

B-mode ultrasound is versatile and safe. The sequelae of aortic disorders in children range from stunted growth in hypoplasia to 90% fatality in ruptured aneurysms. Thus, age-based reference values ar... To create age-based reference values of paediatric aorta diameters from B-mode ultrasound using the outer-to-outer method.... A retrospective review was done of records of peak systolic anteroposterior aortic diameters, obtained during abdominal ultrasound in children ages 2 days to 17 years between January 2016 and December... A total of 643 cases (49% female) were recruited into the study. Only 488 cases (76%) had values for the proximal, mid and distal aorta. The cumulative mean age was 9.5±5.1 years while the mean aortic... An age-based paediatric aortic reference table from B-mode ultrasound using outer-to-outer measurement in a Nigerian population is reported....